138 related articles for article (PubMed ID: 23090059)
1. Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass.
Tsubokawa T; Ishizuka S; Fukumoto K; Ueno K; Yamamoto K
J Anesth; 2013 Apr; 27(2):243-50. PubMed ID: 23090059
[TBL] [Abstract][Full Text] [Related]
2. The effect of hemodilution by cardiopulmonary bypass on protein binding of olprinone.
Tsubokawa T; Ishizuka S; Fukumoto K; Ueno K; Yamamoto K
J Anesth; 2013 Jun; 27(3):346-50. PubMed ID: 23179741
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of olprinone after cardiac surgery.
Mori M; Nishi S; Asada A
Osaka City Med J; 2004 Jun; 50(1):1-8. PubMed ID: 15646253
[TBL] [Abstract][Full Text] [Related]
4. Effects of olprinone, a new phosphodiesterase inhibitor, on gastric intramucosal acidosis and systemic inflammatory responses following hypothermic cardiopulmonary bypass.
Yamaura K; Akiyoshi K; Irita K; Taniyama T; Takahashi S
Acta Anaesthesiol Scand; 2001 Apr; 45(4):427-34. PubMed ID: 11300380
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery.
Bailey JM; Levy JH; Kikura M; Szlam F; Hug CC
Anesthesiology; 1994 Sep; 81(3):616-22. PubMed ID: 8092507
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase III inhibitor olprinone chlorate is not significantly removed by continuous venovenous hemodiafiltration.
Amenomori H; Sasaki S; Hiraoka K; Morimoto Y; Gando S; Kemmotsu O
ASAIO J; 2000; 46(5):635-8. PubMed ID: 11016521
[TBL] [Abstract][Full Text] [Related]
7. Post-operative effects of olprinone after coronary artery bypass grafting.
Orime Y; Shiono M; Hata H; Yagi S; Tsukamoto S; Kimura S; Ohmiya S; Sezai A; Yamada H; Obana M; Sezai Y
Ann Thorac Cardiovasc Surg; 1998 Dec; 4(6):340-6. PubMed ID: 9914463
[TBL] [Abstract][Full Text] [Related]
8. Effect of olprinone, a phosphodiesterase III inhibitor, on balance of cerebral oxygen supply and demand during cardiopulmonary bypass.
Yamanaka H; Hayashi Y; Kamibayashi T; Mashimo T
J Cardiovasc Pharmacol; 2011 May; 57(5):579-83. PubMed ID: 21326107
[TBL] [Abstract][Full Text] [Related]
9. [The effect of olprinone administered after cardio-pulmonary bypass during open heart surgery, evaluated by its plasma concentrations and hemodynamic changes].
Arai T; Takano Y; Mizukami S; Sato I
Masui; 1999 Oct; 48(10):1083-90. PubMed ID: 10554499
[TBL] [Abstract][Full Text] [Related]
10. Effects of phosphodiesterase inhibitors after coronary artery bypass grafting.
Orime Y; Shiono M; Hata H; Yagi S; Tsukamoto S; Okumura H; Kimura S; Hata M; Sezai A; Obana M; Sezai Y
Jpn Circ J; 1999 Feb; 63(2):117-22. PubMed ID: 10084374
[TBL] [Abstract][Full Text] [Related]
11. [Effects of olprinone hydrochloride after coronary artery bypass grafting].
Arai T
Masui; 2004 Feb; 53(2):122-30. PubMed ID: 15011418
[TBL] [Abstract][Full Text] [Related]
12. [Application of a PDE III inhibitor, olprinone, for fast track pediatric cardiac surgery].
Itou M; Okamoto H; Suwa J; Asou T; Hoka S
Masui; 2004 Mar; 53(3):258-63. PubMed ID: 15071874
[TBL] [Abstract][Full Text] [Related]
13. [Effects of olprinone hydrochloride on intraocular pressure and ocular blood flow in patients after cardiac surgery under cardiopulmonary bypass].
Goto K; Hasegawa A; Shingu C; Hayano Y; Yoshitake S; Noguchi T
Masui; 2002 Nov; 51(11):1212-6. PubMed ID: 12481446
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the different doses of olprinone for continuous infusion after cardiopulmonary bypass for coronary artery bypass surgery].
Sha K; Iwata M; Mori M; Motozu Y; Yonemoto N; Kitaguchi K; Hirai K; Furuya H
Masui; 2003 Jun; 52(6):621-5. PubMed ID: 12854477
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of computer-controlled alfentanil administration in children undergoing cardiac surgery.
Fiset P; Mathers L; Engstrom R; Fitzgerald D; Brand SC; Hsu F; Shafer SL
Anesthesiology; 1995 Nov; 83(5):944-55. PubMed ID: 7486179
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass.
De Hert SG; Moens MM; Jorens PG; Delrue GL; DePaep RJ; Vermeyen KM
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):264-71. PubMed ID: 7669958
[TBL] [Abstract][Full Text] [Related]
17. [Differences in hemodynamic effects of amrinone, milrinone and olprinon after cardiopulmonary bypass in valvular cardiac surgery].
Sha K; Shimokawa M; Ishimaru K; Kawaraguchi Y; Takahashi M; Yanaidani F; Kitaguchi K; Furuya H
Masui; 2000 Sep; 49(9):981-6. PubMed ID: 11025952
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. The Multicenter Study of Perioperative Ischemia Research Group.
Bailey JM; Mora CT; Shafer SL
Anesthesiology; 1996 Jun; 84(6):1288-97. PubMed ID: 8669668
[TBL] [Abstract][Full Text] [Related]
19. Time-Varying Clearance in Milrinone Pharmacokinetics from Premature Neonates to Adolescents.
O'Hanlon CJ; Sumpter A; Anderson BJ; Hannam JA
Clin Pharmacokinet; 2024 May; 63(5):695-706. PubMed ID: 38613610
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of lidocaine administered during and after cardiac surgery.
Hsu YW; Somma J; Newman MF; Mathew JP
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):931-6. PubMed ID: 21616681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
